Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date review
Transgender and gender-diverse (TGD) individuals face an elevated risk of cancer in comparison with the general population. This increased risk is primarily attributed to an imbalanced exposure to modifiable risk factors and a limited adherence to cancer screening programmes, stemming from historica...
Saved in:
Main Authors: | Matteo Lambertini, Filippo Pietrantonio, Dario Trapani, Francesco Perrone, Rossana Berardi, Saverio Cinieri, Chiara Cassani, Amelia Barcellini, Filippo Ghelardi, Alberto Giovanni Leone, Stefania Bonadonna, Marianna Sirico, Barbara Tagliaferri, Stefano Maccarone, Davide Dalu, Lorenzo Ruggieri, Simone Nardin, Nicla La Verde |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-07-01
|
Series: | BMJ Oncology |
Online Access: | https://bmjoncology.bmj.com/content/3/1/e000330.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The genetics and hormonal basis of human gender identity
by: Rafael Loch Batista, et al.
Published: (2025-01-01) -
Uncovering the role of mismatch repair deficiency and microsatellite instability in urothelial carcinoma
by: Filippo Pietrantonio, et al.
Published: (2024-07-01) -
Sex hormones and allergies: exploring the gender differences in immune responses
by: Jesús Alberto Gutiérrez-Brito, et al.
Published: (2025-01-01) -
Immune dynamics throughout life in relation to sex hormones and perspectives gained from gender-affirming hormone therapy
by: Ahmet Yalcinkaya, et al.
Published: (2025-01-01) -
Impact of Gonadotropin-releasing Hormone Analogue and Gender-affirming Hormone Therapy on Bone Mineral Density in Transgender Adolescents
by: Marta Chuncia, et al.
Published: (2025-01-01)